---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-014221"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2023-01-24T23:59:59+00:00"
generated_at: "2026-06-20T10:56:23.735384+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Leone Patterson resigns from Eliem Therapeutics board

## Summary
- Leone Patterson resigned from the Board effective Jan 19, 2023, citing no disagreement on operations.
- Board size reduced from 7 to 6 directors.
- Audit Committee reconstituted: Adam Rosenberg (Chair), Simon Tate, Judith Dunn.
- Nominating and Corp Gov Committee: Simon Tate (Chair), Liam Ratcliffe.

## SEC filing metadata
- accession: 0001193125-23-014221
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2023-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312523014221/0001193125-23-014221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312523014221/d412369d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-014221
- JSON: https://secwatch.observer/filing/0001193125-23-014221.json
- Plain text: https://secwatch.observer/filing/0001193125-23-014221.txt

## Key facts
- Executive change
  Leone Patterson resigned as Director at Climb Bio, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 19, 2023, Leone Patterson notified Eliem Therapeutics, Inc. (Eliem, or the Company) of her decision to resign from the Board of Directors of the Company (the Board), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768446/000119312523014221/0001193125-23-014221-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.